Skip to Main Content

Author Details

Ellen L Goode
Mayo Clinic College of Medicine
1995
312
66
PMIDPaper TitleJournal TitlePublished Year
37090539Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival.medRxiv2024
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37339172The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.Clin Cancer Res2023
37369443Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.Can J Surg2023
37168552Multi-trait genome-wide association study identifies a novel endometrial cancer risk locus that associates with testosterone levels.iScience2023
36960831Multiplex Immunofluorescence Image Quality Checking Using DAPI Channel-referenced Evaluation.J Histochem Cytochem2023
36790339Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.Cancer Epidemiol Biomarkers Prev2023
36401943Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.Gynecol Oncol2023
36688720Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.J Natl Cancer Inst2023
34782936MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.Virchows Arch2022
35400525Germline BRCA variants, lifestyle and ovarian cancer survival.Gynecol Oncol2022
35454861CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis.Cancers (Basel)2022
35816189Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.Clin Cancer Res2022
36456881The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.Nat Genet2022
36210504Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.J Natl Cancer Inst2022
35931468Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer.Gynecol Oncol2022
36031730The proteome of clear cell ovarian carcinoma.J Pathol2022
36160147Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma.Front Med (Lausanne)2022
36154123Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors.Circulation2022
34965383Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.Am J Hum Genet2022
34897700Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.J Pathol2022
34789471High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.Cancer Epidemiol Biomarkers Prev2022
34697060DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.Cancer Epidemiol Biomarkers Prev2022
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
34675350Multi-tissue transcriptome-wide association study identifies eight candidate genes and tissue-specific gene expression underlying endometrial cancer susceptibility.Commun Biol2021
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
33407429Generating real-world evidence from unstructured clinical notes to examine clinical utility of genetic tests: use case in BRCAness.BMC Med Inform Decis Mak2021
32608480Gene-based mediation analysis in epigenetic studies.Brief Bioinform2021
32766851Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies.J Natl Cancer Inst2021
32851660Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer.Int J Cancer2021
32905653Circulating CD14<sup>+</sup> HLA-DR<sup>lo/-</sup> monocytic cells as a biomarker for epithelial ovarian cancer progression.Am J Reprod Immunol2021
32413141BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.J Natl Cancer Inst2020
32620889Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.Nat Commun2020
32641237Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.Gynecol Oncol2020
32555365Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.Br J Cancer2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
30487138Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus.Cancer Res2019
31824577Testing Mediation Effects in High-Dimensional Epigenetic Studies.Front Genet2019
31239549A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.Mod Pathol2019
31204077Genes associated with bowel metastases in ovarian cancer.Gynecol Oncol2019
31548585Publisher Correction: Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
30898391Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.Gynecol Oncol2019
30948450Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.Cancer Epidemiol Biomarkers Prev2019
31004097Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts.Sci Rep2019
31001917Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.Cancer Med2019
31076661Going to extremes: determinants of extraordinary response and survival in patients with cancer.Nat Rev Cancer2019
30499236A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants.Int J Cancer2019
30683880Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
  • 1 - 50 of 312

Recommended Authors

Sander Canisius
The Netherlands Cancer Institute
Career Start Year 2011
Number of shared co-authors 73
Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 16
Mitchell J Machiela
National Cancer Institute
Career Start Year 2008
Number of shared co-authors 94
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 2
Katia Nones
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 43
Kouros Owzar
Duke University
Career Start Year 2005
Number of shared co-authors 39
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 44
Markus Riester
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 2
Lisa Mirabello
National Cancer Institute
Career Start Year 2005
Number of shared co-authors 50
Melissa Rotunno
Boston Children's Hospital and Harvard Medical School
Career Start Year 2004
Number of shared co-authors 35
Hisani N Horne
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 33
J??r??mie Nsengimana
Population Health Sciences Institute, Newcastle University
Career Start Year 2004
Number of shared co-authors 9
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 11
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 2
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 14
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 20
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Howard H Yang
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 8
Elad Ziv
Institute for Human Genetics, University of California San Francisco (UCSF)
Career Start Year 2001
Number of shared co-authors 99
Paul Scheet
University of Texas M.D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 46
Sevtap Savas
Memorial University
Career Start Year 1999
Number of shared co-authors 6
Giovanni Parmigiani
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 25
Liang Wang
H. Lee Moffitt Cancer Center
Career Start Year 1996
Number of shared co-authors 26
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 8
Carolyn M Hutter
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 43
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 8
Meredith Yeager
Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 97
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 105
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 52

Collaborators

Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 143
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 139
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 124
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 119
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 119
Andrew Berchuck
Duke School of Medicine
Co-authored papers 108
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 100
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 96
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers 91
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 91
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 90
Honglin Song
University of Cambridge
Co-authored papers 86
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 86
Anna H Wu
University of Southern California
Co-authored papers 85
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 84
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 84
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 79
Hoda Anton-Culver
University of California irvine
Co-authored papers 79
Alice S Whittemore
Co-authored papers 77
Jonathan Tyrer
Co-authored papers 76
Diether Lambrechts
Co-authored papers 74
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers 72
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 71
Douglas F Easton
University of Cambridge
Co-authored papers 70
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 67
Weiva Sieh
Co-authored papers 67
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers 67
Jolanta Lissowska
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 62
Elisa V Bandera
Co-authored papers 60
Graham G Giles
Co-authored papers 59
Release 1.2